1873111460
Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor

Advertise on podcast: Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor

Rating
★★★★☆
3.7
from
9 reviews
This podcast has
155 episodes
Language
English
Publisher
Lindsay Hill
Explicit
No
Date created
2026/01/29
Latest episode
2026/11/13
Average duration
23 min.
Release period
1 days

Description

Welcome to my podcast. I am Lindsay Hill, DNP, PMHNP BC, and this show is my space to slow down and really unpack what psychiatric care looks like in real life. Each episode is built from the learning that shapes our work in mental health: lectures, clinical meetings, medication updates, webinars, books, and the conversations that make you stop and think. We will dig into the details that matter, like diagnostic clarity, treatment planning, psychopharmacology, side effects and monitoring, comorbidities, therapeutic approaches, patient communication, and the practical judgment calls that rarely fit into a tidy script. My goal is simple: take complex topics and make them feel understandable, usable, and grounded. Whether you are a student, a clinician, or someone who loves learning about the mental health field, you will leave with clearer frameworks, helpful reminders, and takeaways you can bring back to your practice and your life. Thanks for being here. Let’s dive in. This podcast is for education and discussion only and is not medical advice.

Unlock Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor podcast


S3E8: PMHNP Sliding Scale Fees: A Private Practice Playbook
2026/11/13
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! A sliding scale can widen access or invite a payer audit. How PMHNPs build a written, income-based fee policy using 2026 federal poverty guideline numbers. In this Deep Dive episode, two hosts walk through “PMHNP Sliding Scale Fees: A Private Practice Playbook” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • A sliding scale is safest for uninsured and true self-pay patients. Federal guidance says discounted care for uninsured people is legal. • For in-network patients, the copay and deductible belong to the insurance contract. Routinely waiving them can break that contract and, with federal programs, raise Anti-Kickback concerns. • Tie the scale to the federal poverty guidelines. In 2026 that is $15,960 for one person and $33,000 for a family of four in the 48 contiguous states. • Cap the number of reduced-fee visits. Three reduced slots out of 24 weekly follow-ups costs a practice $14,400 a year at most in the example below. • Put the policy in writing, verify income the same way for everyone, and review each patient's tier every 12 months. • The risky discount is the informal one made up in the room, not the one in a written policy. Read the full article: https://psychnpfellowship.com/pmhnp-sliding-scale-fees-private-practice-playbook-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S3E7: Duty to Warn: A PMHNP Confidence Script
2026/11/11
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! A patient names someone they want to hurt. Here is how PMHNPs check state duty-to-warn law, size up the threat, talk with the patient, and document the call. In this Deep Dive episode, two hosts walk through “Duty to Warn: A PMHNP Confidence Script” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • Duty-to-warn law is set by each state. Carlat counts mandatory Tarasoff laws in 26 states plus Puerto Rico; others only permit disclosure, and a few have no statutory duty. • The usual trigger is a serious threat of violence against a reasonably identifiable person. Angry venting and intrusive OCD thoughts usually don't meet it. • HIPAA already permits disclosure to prevent a serious and imminent threat (45 CFR 164.512(j)). The real constraint is your state law. • Warning the victim is the last rung, not the first. Intensified treatment, means restriction, and hospitalization often protect better and keep the alliance intact. • Tell the patient what you are doing and why, when it is safe. Then document verbatim quotes, your reasoning, your consults, and every contact attempt. Read the full article: https://psychnpfellowship.com/duty-to-warn-pmhnp-confidence-script-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S3E6: Precepting PMHNP Students: What It Pays You Back
2026/11/10
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! Precepting PMHNP students can earn state tax credits of up to $10,000 a year and fill an ANCC renewal category. Here is the math, the time cost, and the rules. In this Deep Dive episode, two hosts walk through “Precepting PMHNP Students: What It Pays You Back” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • U.S. nursing schools turned away 6,496 qualified master's and 10,359 doctoral applications in 2025, and AACN lists a shortage of preceptors and clinical sites among the reasons. • Maryland gives NP preceptors a $1,000 tax credit per student (90+ hours), up to $10,000 a year. Georgia gives APRNs $750 per 160-hour rotation, up to $7,500. • 120 hours of precepting APRN, medical, PA, or pharmacy students fully meets Category 5 of ANCC certification renewal. • Taking a school's teaching stipend can make you ineligible for a state credit worth more than the stipend. • The real cost is clinic time. Get protected time or adjusted productivity targets in writing before you say yes. Read the full article: https://psychnpfellowship.com/precepting-pmhnp-students-tax-credits-ancc-renewal-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S3E5: Switching Antidepressants: A PMHNP Cross-Taper Protocol
2026/11/09
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! Direct switch, cross-taper, or washout? A step-by-step PMHNP protocol for switching antidepressants safely, with half-life math and MAOI washout rules. In this Deep Dive episode, two hosts walk through “Switching Antidepressants: A PMHNP Cross-Taper Protocol” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • Switch when the first antidepressant gave no meaningful response after an adequate trial or caused side effects the patient won't tolerate. Augment when it gave a partial response. • There are three switching strategies: a direct switch (stop today, start tomorrow), a cross-taper (overlap over 2 to 4 weeks), and a taper plus washout (roughly five half-lives off before starting). • Half-life sets the pace. Fluoxetine tapers itself, while paroxetine and venlafaxine are the drugs most likely to cause discontinuation symptoms. • MAOIs have their own hard rules: wait 5 weeks after fluoxetine, about 2 weeks after most other serotonergic antidepressants, and 2 weeks after stopping an MAOI. • Most day-3-to-day-10 complaints during a switch are discontinuation symptoms, not relapse. Name them for the patient ahead of time. • In STAR*D, about 1 in 4 patients who switched after citalopram reached remission. A switch is a real second chance, not a consolation prize. Read the full article: https://psychnpfellowship.com/switching-antidepressants-cross-taper-pmhnp-protocol-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S3E4: Lethal Means Counseling: A PMHNP Confidence Script
2026/11/08
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! Lethal means counseling for PMHNPs: when to ask about firearms and medications, word-for-word scripts, storage options, and how to document it with confidence. In this Deep Dive episode, two hosts walk through “Lethal Means Counseling: A PMHNP Confidence Script” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • In 2023, firearms accounted for 27,300 of the 49,316 suicide deaths in the US, about 55%. • About 90% of suicide attempts with a firearm end in death, compared with a few percent for most overdoses. • One in four survivors of near-lethal attempts in a Houston study acted less than 5 minutes after deciding to. • Lethal means counseling is a short, voluntary conversation about putting time and distance between a person and a method. It is not confiscation. • Ask everyone with elevated risk, use the same calm tone you use for sleep and appetite, and write down who holds the key. • Your own prescriptions count as lethal means, so quantity, packaging and who holds the bottle belong in the plan. Read the full article: https://psychnpfellowship.com/lethal-means-counseling-pmhnp-confidence-script-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S3E3: SSRI Sexual Dysfunction: A PMHNP Management Protocol
2026/11/05
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! Most patients on SSRIs have sexual side effects but few say so. A PMHNP protocol to screen, wait, lower the dose, switch, or augment without risking relapse. In this Deep Dive episode, two hosts walk through “SSRI Sexual Dysfunction: A PMHNP Management Protocol” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • Sexual side effects are among the most common reasons patients quietly stop an SSRI, and most will not mention it unless you ask. • Screen at baseline and at every follow-up with a short scale like the ASEX or CSFQ-14, so you can separate depression-related problems from drug effects. • Paroxetine carries the highest risk among SSRIs. Bupropion, mirtazapine, and vortioxetine carry lower risk. • The protocol runs in order: confirm, wait one follow-up, lower the dose if the patient is in remission, then switch or augment. • Bupropion add-on has the strongest adjunct evidence. Sildenafil helped both men and women in randomized trials. • Never trade remission for sexual function without a plan. Relapse is the bigger risk. Read the full article: https://psychnpfellowship.com/ssri-sexual-dysfunction-pmhnp-management-protocol-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S3E2: Pharmacogenomic Test Results: A PMHNP Confidence Script
2026/11/04
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! A patient hands you a pharmacogenomic report and wants only green-column meds. Here's what the evidence really shows, plus a word-for-word PMHNP script. In this Deep Dive episode, two hosts walk through “Pharmacogenomic Test Results: A PMHNP Confidence Script” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • In the 1,944-patient PRIME Care trial, pharmacogenomic testing changed which antidepressant patients got far more than it changed whether they reached remission at 24 weeks. • Only CYP2D6, CYP2C19 and CYP2B6 have CPIC dosing guidance for antidepressants. SLC6A4 and HTR2A results should not drive decisions. • A "red" column usually means adjust the dose or monitor more closely, not "never prescribe." • Read the report against the current med list, because strong CYP2D6 inhibitors like bupropion and fluoxetine can override the genotype. • Use the four scripts below to validate the patient's effort, explain what the test can and can't do, and make a shared plan. • Never stop a working medication because a report flags it. Observed response beats predicted metabolism. Read the full article: https://psychnpfellowship.com/pharmacogenomic-test-results-pmhnp-confidence-script-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S3E1: PMHNP Quarterly Estimated Taxes: A 1099 Playbook
2026/11/03
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! A 1099 PMHNP netting $160K owes about $10K in federal tax each quarter. The deadlines, safe harbor rules and set-aside system that keep your April calm. In this Deep Dive episode, two hosts walk through “PMHNP Quarterly Estimated Taxes: A 1099 Playbook” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • 1099 PMHNPs have no employer withholding, so the IRS expects tax paid in four installments: April 15, June 15, September 15 and January 15. • Self-employment tax alone is 15.3% on 92.35% of net earnings, about $22,600 on $160,000 of net income, before any income tax. • You avoid the underpayment penalty if you pay 100% of last year's total tax (110% if last year's AGI topped $150,000) across the four dates. • The penalty works like interest, currently 7% a year on the shortfall, so the bigger danger is a cash crunch in April, not the penalty itself. • If you also have a W-2 job, raising your W-4 withholding can cover your side income, and withholding counts as paid evenly all year. • Move 25% to 30% of every deposit into a separate tax account the day it lands, and pay each quarter from that account only. Read the full article: https://psychnpfellowship.com/pmhnp-quarterly-estimated-taxes-1099-playbook-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S2E99: Antipsychotic Metabolic Monitoring: A PMHNP Protocol
2026/11/03
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! Only 28.9% of antipsychotic patients got lipid tests even after guidelines. Use this PMHNP schedule, the 3-5-7 weight rule, and clear lab action thresholds. In this Deep Dive episode, two hosts walk through “Antipsychotic Metabolic Monitoring: A PMHNP Protocol” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • Order weight, BMI, waist, blood pressure, A1c or fasting glucose and a lipid panel before the first dose, not at the first follow-up. • Recheck weight at weeks 4, 8 and 12, repeat labs and blood pressure at 12 to 16 weeks, then keep checking at least annually. • Use the 3-5-7 rule: more than 3% gain raises metformin, 5% or more raises a switch, and 7% or more is clinically significant gain. • Glucose and lipids can shift within weeks, before the scale moves, so a stable weight does not clear a patient. • A nonfasting lipid panel works for most patients. Repeat it fasting if triglycerides come back at 400 mg/dL or higher. Read the full article: https://psychnpfellowship.com/antipsychotic-metabolic-monitoring-pmhnp-protocol-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S2E98: Federal Deprescribing Push: What PMHNPs Should Do Now
2026/11/03
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! HHS wants psychiatric medications reviewed more often, but its letter binds no one. What PMHNPs should change in consent, charting and Medicare billing. In this Deep Dive episode, two hosts walk through “Federal Deprescribing Push: What PMHNPs Should Do Now” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • HHS announced its psychiatric overprescribing action plan on May 4, 2026. The clinician letter that came with it uses the word “encourages” and sets no new prescribing rule. • Formal HHS guidance on tapering was supposed to follow a July expert panel. This review found no published version as of November 1, 2026. • The best evidence you can use today is a 2026 consensus statement in JAMA Network Open: 45 experts, 44 of 50 statements agreed, and 100% agreement on reviewing every psychotropic at least once a year. • CMS confirmed that between-visit taper work can count toward care management codes. Nurse practitioners can bill general behavioral health integration (CPT 99484) if every requirement is met. • Patients may hear the headline before they hear from you, so an abrupt self-directed stop is the near-term risk to plan for. Read the full article: https://psychnpfellowship.com/federal-deprescribing-push-pmhnp-guide-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S2E97: Patients Who Secretly Stop Meds: A PMHNP Script
2026/11/03
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! About 1 in 5 antidepressant users stops without a prescriber's OK. Here is the question, script and restart check PMHNPs need when a patient quits meds. In this Deep Dive episode, two hosts walk through “Patients Who Secretly Stop Meds: A PMHNP Script” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • In a Psychiatric Services analysis of 1,411 antidepressant users, 22% stopped without a clinician's advice or approval. • “Have you been taking your medication?” almost always gets a yes. Christoph Correll, MD, suggests asking how many doses were missed since the last visit. • Fewer reported side effects can be the first sign of partial adherence, because clinical worsening may show up late. • A disclosure needs a safety check before anything else. Find out what was stopped, when, and why, then screen for risk and withdrawal. • Never say “just restart it” by reflex. Lamotrigine and clozapine both have gap rules that can require re-titration. • Check adherence before you raise a dose, add an agent or call anything treatment-resistant. Read the full article: https://psychnpfellowship.com/patient-secretly-stopped-medication-pmhnp-script-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S2E96: HIPAA Risk Analysis: A Solo PMHNP Practice Playbook
2026/11/03
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! A Maryland psychiatric practice paid $40,000 after ransomware. Here is how a solo PMHNP builds the HIPAA risk analysis OCR asks to see, one step at a time. In this Deep Dive episode, two hosts walk through “HIPAA Risk Analysis: A Solo PMHNP Practice Playbook” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • A Maryland psychiatric practice paid $40,000 and accepted three years of OCR monitoring after a ransomware attack, and OCR cited the lack of an accurate, thorough risk analysis. • HIPAA has no small-practice exemption from the risk analysis requirement. Your size changes how much you need to do, and whether you need to do it stays the same. • A solo version comes down to three documents: an inventory of where patient data lives, a scored risk register, and a dated fix list. • Your EHR vendor's compliance covers the vendor. Your laptop, your phone, your email and any AI scribe without a signed agreement are still yours to assess. • Keep the documentation for six years, and redo the analysis at least yearly and after any incident or new technology. Read the full article: https://psychnpfellowship.com/hipaa-risk-analysis-solo-pmhnp-practice-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S2E95: Orexin Antagonists for Insomnia: A PMHNP Protocol
2026/11/03
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! A PMHNP protocol for suvorexant, lemborexant, and daridorexant: who fits, dosing, CYP3A and liver limits, and switching patients off benzodiazepines for sleep. In this Deep Dive episode, two hosts walk through “Orexin Antagonists for Insomnia: A PMHNP Protocol” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • The 2017 AASM guideline suggests suvorexant for sleep-maintenance insomnia and suggests against trazodone, yet trazodone and quetiapine remain the default sleep scripts in many psychiatric clinics. • Three dual orexin receptor antagonists (DORAs) are FDA-approved: suvorexant (10 to 20 mg), lemborexant (5 to 10 mg), and daridorexant (25 to 50 mg). All are Schedule IV. • DORAs block the brain's wake signal instead of sedating the whole brain, and they do not carry the complex-sleep-behavior boxed warning that zolpidem, zaleplon, and eszopiclone carry. • Check CYP3A inhibitors and liver function before you prescribe. Strong CYP3A inhibitors rule out all three, and narcolepsy is a contraindication. • In one 228-patient cohort, switching from a benzodiazepine to suvorexant had about half the dropout rate of adding it on (24.4% vs 45.0%). • CBT-I stays first-line. A DORA is a tool you add to behavioral treatment, not a replacement for it. Read the full article: https://psychnpfellowship.com/orexin-antagonist-insomnia-pmhnp-protocol-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S2E94: Negative Online Reviews: A PMHNP HIPAA Response Script
2026/11/03
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! A psychiatry practice paid $30,000 over its Google review replies. Use this HIPAA-safe script to answer a negative online review without disclosing PHI. In this Deep Dive episode, two hosts walk through “Negative Online Reviews: A PMHNP HIPAA Response Script” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • In 2023, a New Jersey psychiatry practice paid HHS $30,000 after replying to four patients' Google reviews with details of their diagnoses and treatment. • Confirming that a reviewer is your patient is itself a disclosure of protected health information, even if the patient named themselves first. • A patient posting their own story publicly does not give you permission to add to it. • The safe public reply is short and generic: thank them, state your privacy policy, and invite a private conversation by phone. • Handle the real complaint offline, document it, and write a one-page review policy so nobody on staff replies in anger. Read the full article: https://psychnpfellowship.com/negative-online-review-pmhnp-hipaa-response-script-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.
S2E93: PMHNP Malpractice Tail Coverage: Who Pays When You Leave
2026/11/03
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! Leaving a PMHNP job on a claims-made policy? Tail coverage can cost up to 3x a yearly premium. Learn who pays and what to lock down before you resign. In this Deep Dive episode, two hosts walk through “PMHNP Malpractice Tail Coverage: Who Pays When You Leave” from the Psych NP Fellowship blog by Lindsay Hill, DNP, PMHNP-BC. Key takeaways: • Tail coverage (an extended reporting endorsement) lets a claims-made malpractice policy answer claims filed after you leave a job. • A review in the Journal of Oncology Practice put tail at “often three times” an annual premium. Many quotes land between 150% and 300%. • If your employer's policy is occurrence-based, you usually don't need tail at all. Confirm the policy type in writing before you sign. • Who pays comes down to contract wording. A common split: the employer pays if it ends the job without cause, and you pay if you resign. • Prior-acts (“nose”) coverage from your next employer's carrier can replace a tail purchase if its retroactive date reaches back far enough. • Get a written tail quote and the purchase deadline before you hand in notice. Read the full article: https://psychnpfellowship.com/pmhnp-malpractice-tail-coverage-leaving-job-2026/ Explore the Psych NP Fellowship: https://psychnpfellowship.com/programs/ This content is for educational purposes and does not replace individualized clinical judgment or supervision.

Podcast reviews

Read Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor podcast reviews


3.7 out of 5
9 reviews
★☆☆☆☆
saraleelucas 2026/10/09
Omg it IS AI!!!
La-mo-tri-genie took the professionalism right out of what could have been great material :( Not sure I will make it to the (I assume) se-leg-ah-lenie...
★☆☆☆☆
jmichp88 2026/03/09
AI podcast
Okay so I am a PMHNP student and was so disappointed when I clicked on this show. I use speechify to build podcasts of my textbook readings to help m...
check all reviews on apple podcasts

Podcast sponsorship advertising

Start advertising on Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor relevant audience podcasts


What do you want to promote?